Issue Information
Cancer cachexia—when proteasomal inhibition is not enough
Cardiac cachexia : hic et nunc
Adiponectin resistance in skeletal muscle : pathophysiological implications in chronic heart failure
Accelerometer‐determined physical activity, muscle mass, and leg strength in community‐dwelling older adults
Caloric restriction and aerobic exercise in sarcopenic and non‐sarcopenic obese women : an observational and retrospective study
Sarcopenia and mortality among a population‐based sample of community‐dwelling older adults
High risk of fall, poor physical function, and low grip strength in men with fracture—the STRAMBO study
Factors associated with skeletal muscle mass, sarcopenia, and sarcopenic obesity in older adults : a multi‐continent study
Anti‐sarcopenic effects of diamino‐diphenyl sulfone observed in elderly female leprosy survivors : a cross‐sectional study
Increased expression of H19/miR‐675 is associated with a low fat‐free mass index in patients with COPD
Effect of the specific proteasome inhibitor bortezomib on cancer‐related muscle wasting
Espindolol for the treatment and prevention of cachexia in patients with stage III/IV non‐small cell lung cancer or colorectal cancer : a randomized, double‐blind, placebo‐controlled, international multicentre phase II study (the ACT‐ONE trial)
Cancer cachexia causes skeletal muscle damage via transient receptor potential vanilloid 2‐independent mechanisms, unlike muscular dystrophy
UBE2B is implicated in myofibrillar protein loss in catabolic C2C12 myotubes